These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 38764008

  • 1. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G, Centis R, Migliori GB, Spanevello A.
    BMC Pulm Med; 2024 May 19; 24(1):247. PubMed ID: 38764008
    [Abstract] [Full Text] [Related]

  • 2. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER, SPIROMICS investigators.
    Lancet Respir Med; 2017 Dec 19; 5(12):956-967. PubMed ID: 29146301
    [Abstract] [Full Text] [Related]

  • 3. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.
    Park HY, Lee H, Koh WJ, Kim S, Jeong I, Koo HK, Kim TH, Kim JW, Kim WJ, Oh YM, Sin DD, Lim SY, Lee SD, KOLD Study Group.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 19; 11():23-30. PubMed ID: 26730185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE, Bleecker ER, Panettieri RA, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R.
    Lancet Respir Med; 2014 Nov 19; 2(11):891-901. PubMed ID: 25208464
    [Abstract] [Full Text] [Related]

  • 7. Association between COPD exacerbations and lung function decline during maintenance therapy.
    Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JW, Sadatsafavi M, Sin DD, Carter V, Price DB.
    Thorax; 2020 Sep 19; 75(9):744-753. PubMed ID: 32532852
    [Abstract] [Full Text] [Related]

  • 8. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA.
    Respir Med; 2011 Dec 19; 105(12):1853-60. PubMed ID: 21802933
    [Abstract] [Full Text] [Related]

  • 9. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Mathioudakis AG, Bikov A, Foden P, Lahousse L, Brusselle G, Singh D, Vestbo J.
    Eur Respir J; 2020 May 19; 55(5):. PubMed ID: 32108044
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Kunz LI, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HA, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS, GLUCOLD Study Group.
    Eur Respir J; 2017 Jan 19; 49(1):. PubMed ID: 28049170
    [Abstract] [Full Text] [Related]

  • 13. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.
    COPD; 2019 Apr 19; 16(2):152-159. PubMed ID: 31117850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
    Tashkin DP, Strange C.
    Int J Chron Obstruct Pulmon Dis; 2018 Apr 19; 13():2587-2601. PubMed ID: 30214177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
    Chou KT, Su KC, Hsiao YH, Huang SF, Ko HK, Tseng CM, Su VY, Perng DW.
    Arch Bronconeumol; 2017 Oct 19; 53(10):547-553. PubMed ID: 28438346
    [Abstract] [Full Text] [Related]

  • 19. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Lung; 2006 Oct 19; 184(4):217-22. PubMed ID: 17006748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.